Application Nr Approved Date Route Status External Links
ANDA207864 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Eptifibatide Injection Is A Platelet Aggregation Inhibitor Indicated For: Treatment Of Acute Coronary Syndrome (Acs) Managed Medically Or With Percutaneous Coronary Intervention (Pci) ( 1.1 ) Treatment Of Patients Undergoing Pci (Including Intracoronary Stenting) ( 1.2 ) 1.1 Acute Coronary Syndrome (Acs) Eptifibatide Injection Is Indicated To Decrease The Rate Of A Combined Endpoint Of Death Or New Myocardial Infarction (Mi) In Patients With Acs (Unstable Angina [Ua]/non-St-Elevation Myocardial Infarction [Nstemi]), Including Patients Who Are To Be Managed Medically And Those Undergoing Percutaneous Coronary Intervention (Pci). 1.2 Percutaneous Coronary Intervention (Pci) Eptifibatide Injection Is Indicated To Decrease The Rate Of A Combined Endpoint Of Death, New Mi, Or Need For Urgent Intervention In Patients Undergoing Pci, Including Those Undergoing Intracoronary Stenting [See Clinical Studies (14.1 , 14.2) ] .

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Eptifibatide EPTIFIBATIDE ZINC85536935

Comments